Rare diseases
Investigational molecules
Locations
Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo
PolandLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
PolandBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
PolandLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
PolandA study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer's disease
PolandA study to evaluate the effectiveness and safety of pridopidine hydrochloride in patients with amyotrophic lateral sclerosis
PolandA study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer
PolandPhase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury
PolandA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
